Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
Figure 3
MRM ion chromatograms of atazanavir in (a) double blank plasma (without analyte and IS), (b) at LLOQ and atazanavir-d6, and (c) in real subject sample.
